Filtros de búsqueda

Lista de obras de Vincenzo Sforza

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.

artículo científico publicado en 2016

Clinical management of advanced gastric cancer: the role of new molecular drugs.

artículo científico

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.

artículo científico publicado en 2017

Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme.

artículo científico publicado en 2017

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

scientific article published on 01 March 2019

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

scientific article published on 16 August 2019

First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age

scientific article published on 01 October 2019

Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells

artículo científico publicado en 2013

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

scientific article published on 01 September 2020

Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer

artículo científico publicado en 2016

Pembrolizumab in lung cancer: current evidence and future perspectives

scientific article published on 21 August 2019

Present and future of metastatic colorectal cancer treatment: A review of new candidate targets

artículo científico publicado en 2017

Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.

artículo científico publicado en 2014

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

artículo científico publicado en 2017

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case.

artículo científico publicado en 2018

The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer

artículo científico publicado en 2020

Treatment of gastric cancer

artículo científico publicado en 2014

Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

scientific article published on 08 May 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda